header
Image from OpenLibrary

Synthesis and evaluation of the cytotoxic activity of certain substituted benzopyrone derivatives / Marwa Samara Abbas Mohamed ; Supervised Fatma Abdelfattah Ragab , Enayat Ibrahim Aly , Heba Abdelrasheed Allam

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Marwa Samara Abbas Mohamed , 2021Description: 141 P . : charts ; 25cmOther title:
  • تشييد لبعض مشتقات البنزوبيرون وتقييم فاعليتها المضادة للخلايا السرطانية [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutical Chemistry Summary: Cancer continues to be one of the most serious life-threatening diseases. The serious development of drug resistant, particularly multidrug-resistant cancers make a tremendous request for novel anticancer drugs. Hybridization of coumarin moieties with different anticancer moieties is a promising strategy to reduces side effects, overcomes drug resistance and provides a valuable therapeutic intervention for treatment of cancer. Herein, twenty-five compounds were designed and synthesized by hybridizing coumarin with different pyrazole and pyrazoline moieties. The synthesized compounds were tested in the NCI against 60 human tumor cell lines according to the anticancer drug screening program where compounds VIIId, XId, XIIc, XVI and XVIIIa showed potent antitumor activity with low IC50 against different cell lines. Additionally, the most active compounds were tested for epidermal growth factor receptor EGFR, cyclo-oxygenase COX-2 and telomerase reverse transcriptase TERT enzymes inhibition assays. Cell cycle analysis and apoptosis of compounds VIIId, XId, XIIc and XVI have been accomplished. A molecular docking study for the most active compounds on the active site of the enzymes; EGFR (PDB: 1M17), COX-2 (PDB: 3LN1), TERT (PDB: 5CQG) was achieved to explore the interaction of these compounds with the active sites
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.05.M.Sc.2021.Ma.S (Browse shelf(Opens below)) Not for loan 01010110085388000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.05.M.Sc.2021.Ma.S (Browse shelf(Opens below)) 85388.CD Not for loan 01020110085388000

Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutical Chemistry

Cancer continues to be one of the most serious life-threatening diseases. The serious development of drug resistant, particularly multidrug-resistant cancers make a tremendous request for novel anticancer drugs. Hybridization of coumarin moieties with different anticancer moieties is a promising strategy to reduces side effects, overcomes drug resistance and provides a valuable therapeutic intervention for treatment of cancer. Herein, twenty-five compounds were designed and synthesized by hybridizing coumarin with different pyrazole and pyrazoline moieties. The synthesized compounds were tested in the NCI against 60 human tumor cell lines according to the anticancer drug screening program where compounds VIIId, XId, XIIc, XVI and XVIIIa showed potent antitumor activity with low IC50 against different cell lines. Additionally, the most active compounds were tested for epidermal growth factor receptor EGFR, cyclo-oxygenase COX-2 and telomerase reverse transcriptase TERT enzymes inhibition assays. Cell cycle analysis and apoptosis of compounds VIIId, XId, XIIc and XVI have been accomplished. A molecular docking study for the most active compounds on the active site of the enzymes; EGFR (PDB: 1M17), COX-2 (PDB: 3LN1), TERT (PDB: 5CQG) was achieved to explore the interaction of these compounds with the active sites

Issued also as CD

There are no comments on this title.

to post a comment.